It has been proposed in human colorectal cancers (CRC) a minority subset of cancer cells within tumors able to initiate tumor growth, defined as cancer stem cells (CSC). Solid human primary colonic and its ovarian metastatic cancer tissues were collected from fresh surgical samples and subsequent xenografts were established in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. The resulting tumors were disaggregated into single-cell suspensions and a CD133 − cell line (NANK) was newly established and analyzed by flow cytometry. Surface markers of progenitor cells were immunophenotypically analyzed, and expression of stem cell and cancer-related genes was characterized. Secreted angiogenesis-associated molecules were investigated by proteomic array technology. Finally, different numbers of NANK were implanted and their tumor-initiating properties were investigated in NOD/SCID mice. Intraperitoneal injection of NANK in NOD/SCID mice induced tumors with developing progressive peritoneal dissemination and ascites. NANK cells maintained a differentiated phenotype and reproduced the full morphologic and phenotypic heterogeneity of their parental lesions. Noticeably, NANK lacked the expression of conventional CSC markers CD133 and CD44, self-renewal genes Oct-4 and Nanog, but showed the expression of an important gastrointestinal development marker CDX-2 and BMI-1 that is essential in regulating the proliferative activity of normal and leukemic stem cells. In addition, NANK secreted high amounts of important angiogeneic cytokines. These results provide a novel and extensive model in human CSC for studying the generation and maintenance of phenotypic heterogeneity in CRC.
INTRODUCTION
655,000 deaths worldwide each year (18) . Although advances have been made in colon cancer therapies, most cancer deaths still result from metastatic disease, being Colon carcinoma is considered to be the third most common form of cancer and the second leading cause the largest hurdle for successful tumor treatment. Unfortunately, there is a poor understanding of the molecular of cancer-related death in the Western world, causing mechanisms responsible for the local or disseminated sue fragments were implanted separately in different mice. metastasis, thus impeding progress on effective therapies.
Isolation and In Vitro Expansion of Tumor Cells Colon carcinoma often metastasizes to different loca-From a Xenograft Derived From Colon Metastasis tions, among them the ovary where 5-10% of malignant to the Ovary tumors involving this organ are metastatic and are frequently mistaken for the primary ovarian carcinoma A solid tissue collected from mouse xenograft was mechanically and enzymatically disaggregated into sin-(47). Colonic adenocarcinoma accounts for 37-45% of all metastatic ovarian tumors (25) and the distinction of gle-cell suspension and incubated with 200 U/ml of collagenase type IV (Sigma) and DNase I (Roche) for 1 h metastatic ovarian carcinoma from the primary malignant ovarian neoplasm is crucial to its subsequent man-at 37°C to obtain enzymatic dissociation. Cells were then resuspended by pipetting and serially filtered by agement, because diagnostic misinterpretation may have important adverse consequences for the patient.
using sterile gauze and, 100-and 40-µm nylon meshes. After filtration, cells were plated at 10,000 cells/ml in a Recently, it has been proposed that stem cells play a role in the development and progression of tumors. The T25 flask on DMEM (GibcoBRL/Invitrogen, Co.) supplemented with 10% FBS (Cansera International, Inc, concept of cancer stem cells (CSC) has been suggested as cells with the ability to self-renew and to produce Ontario, Canada) and 120 µg/ml penicillin, 100 µg/ml streptomycin, at 37°C in a humidified atmosphere with the heterogeneous lineages of cancer cells that comprise tumors (24, 35) . More importantly, CSC may not only be 5% carbon dioxide. The medium was routinely changed every 2-3 days. Cells derived from this ovarian tissue associated with tumor initiation and growth but may also play a crucial role in tumor metastasis (14) . The progno-were designated as NANK. sis of patients with metastatic colorectal carcinoma is
Immunofluorescence Study poor despite recent advances in diagnostic and therapeutic techniques (9, 21, 42) . An understanding of the biolog-NANK, human colon adenocarcinoma cell line Colo320 (ATCC), and human ovarian mucinous adenocarcinoma ical nature of this neoplasm is needed to improve the prognosis of patients. In vitro stable growing human cell line JHOS-2 (purchased from Summit Pharmaceuticals Intl. Corp., Japan) were grown in eight-chamber CRC cell lines can be the most suitable tool for this purpose, because such cells are applicable to a variety culture slides and then fixed with 4% paraformaldehyde. The slides were subjected to double immunofluores-of experiments to understand tumor biology and the role of CSC. cence using anti-CDX 2 mAb and anti-actin mAb (Millipore Japan, Tokyo, Japan). Cy3-labeled goat anti-rabbit We have established a tumor-initiating cell line NANK that does not share characteristics with the pre-IgG and FITC-labeled goat anti-mouse IgG (Jackson Im-unoResearch Laboratories, Inc., West Grove, PA) were viously reported CSC. In the present study, we described the cell phenotype of NANK, including the in vitro and used as secondary antibodies. Hoechst33258 (Sigma Aldrich Japan, Japan) was used for nuclear counterstain-in vivo growth characteristics and the gene expression profile.
ing. In another set of experiments, NANK, Colo320, and another human colon cancer cell line, WiDr, were Utilization of NANK could contribute to the development of CSC research by providing a novel biological stained to evaluate the expression of cytokeratin 7 (CK 7) and cytokeratin 20 (CK 20) using anti-human CK 7 feature of CSC, which may lead to finding future therapeutic targets on colon cancer-initiating cells. mAb (Abcam, clone Ks20.8, Tokyo, Japan) and antihuman CK 20 mAb (Abcam, clone OV-TL 12/30, MATERIALS AND METHODS Tokyo, Japan). Cy3-labeled goat anti-mouse IgG (Jack-Tumor Tissues and Xenograft Preparation son ImunoResearch Laboratories, Inc.) was used as secondary antibody. Tumor tissues were obtained from colorectal primary and metastasis to the ovary from a 41-year-old Japanese Reverse Transcriptase-Polymerase Chain Reaction female, with a T4 N4 M1 Stage IV advanced colon can-(RT-PCR) Analysis cer. The Ethics Committee of Okayama University Hospital approved this study and the subject gave her in-Total RNA was extracted from NANK cells using TRIzol (Invitrogen) reagent according to the manufac-formed consent for participation in the present study.
Briefly, the colonic and ovarian tissue specimens turer's instructions. Reverse transcription (RT) was performed at 22°C for 10 min, followed by 42°C for 20 were minced with scissors into small (2 mm 3 ) fragments and implanted intraperitoneally through a small incision min, using specific primers with 2.0 µg of RNA per reaction. The following primers were used: Oct-4, sense on the animal's abdominal cavity into 6-8-week-old NOD/SCID mice (Charles River Laboratories). The tis-5′-GAGCAAAACCCGGAGGAGT-3′ and antisense 5′-TTCTCTTTCGGGCCTGCAC-3′; nanog, sense 5′-GC derived conditioned medium was analyzed using a highdensity protein array according to the manufacturer's in-TTGCCTTGCTTTGAAGCA-3′ and antisense 5′-TTC TTGACTGGGACCTTGTC-3′; BMI-1, sense 5′-GGA structions. Serum-free DMEM was used as a control.
GACCAGCAAGTATTGTCCTTTTG-3′ and antisense
Flow Cytometry and Cell Sorting Experiments 5′-CATTGCGCTGGGCATCGTAAG-3′; P53, sense 5′-CTGAGGTTGGCTCTGACTGTACCACCATCC-3′ and NANK was magnetically labeled and separated by double passage using a human CD133 cell isolation kit antisense 5′-CTCATTCAGCTCTCGGAACATCTCGA AGCG-3′; APC, sense 5′-TCATGATAAGGATGAT (Miltenyi Biotec). Before separation, samples were assessed using a FACSCalibur flow cytometer, mouse ATGTCGC-3′ and antisense 5′-AATTCTGCAATGGC CTGTAGTC-3′; Bcl-xL, sense 5′-GGAAAGCGTAGA IgG2b conjugated to APC was used as isotype control (Miltenyi Biotec). CD133 expression was assessed using CAAGGAGATGC-3′ and antisense 5′-GGTGGGAGG GTAGAGTGGATGGT-3′; caspase 3, sense 5′-TGAT human anti-CD133/1(AC133)-Biotin (Miltenyi Biotec). At least 10,000 events were acquired for each sample GATGTGGAAGAACTTAGG-3′ and antisense 5′-AC GGCTCCGCACCTGCTGAGGC-3′; CD133, sense 5′-and all cells positive for propidium iodide were gated out. After magnetic bead separation, samples were as-ACATGAAAAGACCTGGGGG-3′ and antisense 5′-GA TCTGGTGTCCCAGCATG-3′; CD44, sense 5′-CCAA sessed by flow cytometry to define purity. GATGATCAGCCATTCTGG-3′ and antisense 5′-AA Transplantation of NANK Cells in NOD/SCID Mice GACATCTACCCCAGCAAC-3′; and GAPDH, sense 5′-TCCCCATCACCATCTTCCAG-3′ and antisense 5′-Six-to 8-week-old NOD/SCID mice (Charles River Laboratories) were used as recipients. All animal proce-GAGTCCTTCCACGATACCAA-3′.
PCR products were resolved on 1% agarose gels and dures were approved by the Okayama University Institutional Animal Care and Use Committee, and thus within visualized by ethidium bromide staining. Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served the guidelines for human care of laboratory animals. CD133 − NANK at a density of 1 × 10 4 , 5 × 10 4 , and as an internal control for cDNA synthesis. mRNA expression levels were normalized relative to GAPDH and 1 × 10 5 were diluted in 500 µl of Matrigel and transplanted into the peritoneal cavity of the mice (n = 3) for expressed as folds of relative intensity. each dilution. All mice were sacrificed when tumors Irradiation Experiments, MTS and FACS Analyses were palpable measured 10 mm, or at the first sign of suffering, between 8 and 12 weeks posttransplantation. NANK and SW620 were cultured at a density of 3 × 10 4 cells per well in flat-bottomed 96-well plates. After
Histological and Immunohistochemical Analyses 24 h cells were irradiated with 4 Gy. Forty-eight hours after irradiation, the cell viability was determined MTS At the time of sacrifice, tumors were removed and fixed in 20% formalin, and embedded in paraffin. Serial assay, according to the manufacturer's instructions, and the absorbance was measured at 492 nm. tissue sections were cut and stained with hematoxylin and eosin. Fixed, paraffin-embedded tissue sections To determine the percentage of CD133 and CD44 cells after irradiation in NANK, 1 × 10 6 cells were were then examined immunohistochemically using the mouse monoclonal antibody to human CK 7, CK 20 plated in T75 flasks in DMEM supplemented with 10% FBS. Twenty-four hours later, cells were subjected to (DakoCytomation, Carpinteria, CA), p53, p21 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), PCNA irradiation at 4 Gy. The cells were collected 48 h after irradiation, stained with anti-CD133 and anti-CD44 anti-(NOVOCASTRA Laboratories, UK) rabbit antibody to human CDX-2 (BioGenex, San Ramon, CA). Tissue bodies, and analyzed by FACS. As an isotype control, CD133-APC and IgG2b-APC (Miltenyi Biotec) and sections were stained with an automated immunostainer (Ventana XT system BENCHMARK, Ventana, Japan) IOTest CD44-FITC and IgG1-FITC (Miltenyi Biotec) were used for CD133 and CD44 staining, respectively.
using heat-induced epitope retrieval and standard DAB detection kit (Ventana). For detection of each signal, en-Protein and Cytokine Assays dogenous peroxidase activity was quenched by immersion in 3% hydrogen peroxide for 10 min, before the NANK was maintained in DMEM, supplemented with 10% FBS and 100 U/ml penicillin, 0.1 mg/ml process by automated imunohistochemistry. Tissue sections were also stained with CD133/1 (AC133 Miltenyi streptomycin. When confluent (>90% of the surface is covered) in T25 flasks, the cells were shifted to serum-Biotec) or with anti-human CD44 (G44-26, BD Pharmingen TM ) by employing the automated immunostainer. free DMEM medium and cultured 24 h, at 37°C and 5% CO 2 . Conditioned medium (CM) was then collected and Samples were examined under a confocal laser scanning microscope (LSM510, Carl Zeiss, Germany). Primary passed through a 0.45-µm filter membrane (Sartorius, Hannover, Germany). The composition of NANK-colon, metastatic ovarian tissue samples obtained from the patient, as well as colon and ovarian xenograft tis-morphology when subconfluent, whereas when confluent the cells showed cobblestone-like shape ( Fig. 2A ). sues were also prepared for staining.
NANK maintained the consistent morphology from the Statistical Analyses primary culture to the following passages. After cryo-Mean values are presented with SDs. Significance preservation, thawed NANK was able to propagate in was determined by t-test using p < 0.05 as significant.
culture without noticeable change in growth and morphology ( Fig. 2B ). NANK has grown continuously in RESULTS vitro for more than 18 months.
Patient Characteristics
Characterization of NANK We obtained colon and ovary tumor specimens from
The expression of CDX-2, an intestine-specific trana 41-year-old female with advanced colon cancer Stage scription factor that regulates both proliferation and dif-IV. Before surgery her CEA serum levels were 741 µg/ ferentiation in intestinal epithelial cells, was evaluated L [normal range is 0-2.5 µg/L (less than 3 ng/ml)], in NANK. NANK revealed nuclear-positive staining of CA19-9 levels were 1607 U/ml (normal levels less than CDX-2 ( Fig. 2C ), but the human ovarian adenocarci-40 U/ml), and the serum marker CA125 for ovarian carnoma cell line JHOS-2, used as a negative control, was cinoma was 33.1 U/ml (normal values range from 0 to almost negative for CDX-2 expression ( Fig. 2D ). On the 35 U/ml).
other hand, CDX-2 was clearly expressed in Colo320 The Xenograft Tissues Recapitulated the Histological (Fig. 2E ). To further confirm whether NANK is of co-Characteristics of the Parental Tumors lonic origin, we examined the expression of CK7 and CK20 in NANK on the basis of the previously accumu-The colon primary tumor and its metastatic foci to lated surveys (9, 18) . Typically, most of the colonic adethe ovary as well as the xenografts in NOD/SCID mice nocarcinomas are CK 7 − /CK 20 + , whereas ovarian adeshared similar characteristics ( Fig. 1) . On microscopic nocarcinomas are usually CK 7 + /CK 20 − . In accordance examination, both the colon primary tumor and its metawith the staining pattern of CK 7 and CK 20 observed static foci to the ovary showed predominantly moderin the primary colon and metastatic ovarian tumors, the ately differentiated adenocarcinoma with fused glands, expressional pattern of these two markers in NANK was and mucin production, which was mixed with poorly completely consistent with those of the parental colon differentiated adenocarcinoma at deeper site of invasion tumor (CDX-2 + /CK 20 + /CK 7 − ) ( Fig. 3A) . Examining (Fig. 1A, B ). Noticeably, both the colon and the ovary the two representative human colon cancer cell lines xenografted tumors were as well moderately differenti-Colo320 and WiDr as comparative examples for NANK, ated adenocarcinoma in combination with multiple CK 7 expression was almost negative in Colo320, poorly differentiated adenocarcinoma foci, some parts of whereas in WiDr faintly expressed it (Fig. 3A) . which showed mucin production and they histologically To further characterize NANK, a genetic expression were partially similar to those in primary lesion from analysis was performed and shown in Figure 3B . NANK the patient (Fig. 1C, D) . lacked the expression of the putative stem cell markers The primary colon and metastatic ovarian tumors Oct-4 and Nanog. However, it had a very intense expreswere positive for CK 20 and CDX-2 ( Fig. 1A, B) , an sion of the proto-oncogene BMI-1 ( Fig. 3B, C ). Both of important nuclear transcription factor involved in intestithe tumor suppressor genes p53 and APC were present nal-type differentiation, and they showed absence of CK in NANK cells, two markers well known for being mu-7 ( Fig. 1A, B ). This combination of markers has been tated in most cancer cell lines (28, 40) . The antiapoptotic useful to distinguish between primary and metastatic tugene Bcl-xL was expressed in NANK, whereas the promors from colon origin (41) . Xenograft tissues showed apoptotic gene caspase-3 was absent. As for the surface a very similar pattern, with positivity for CK 20 and markers, CD133 and CD44, both were absent in NANK CDX-2 and absence of CK 7 (Fig. 1C, D) . cells (Fig. 3B, C) . Taking these data together, NANK Establishment and Long-Term Culture of NANK cells display specific tumor properties. Reactivation of cytoprotective pathways may provide NANK with the An intraperitoneal xenograft model was used in an attempt to establish a cell line derived from a metastatic ability to escape conventional anticancer treatments. ovarian tumor of a patient with primary colon cancer.
CSC Markers (CD133/CD44) Did Not Emerge After 6-8 weeks, the xenograft tissue was explanted and in NANK After Irradiation isolation of the cells was performed. We successfully established a new cell line from the ovarian tumor speci-It has been reported that CSC, specifically CD133 and CD44 populations, can be enriched after irradiation men and it was designated NANK. The NANK cells grew as an adherent monolayer, showing spindle-like (3,33). To evaluate whether irradiation could enhance CD133 or CD44 subsets in our cell line, NANK cells cell survival (Fig. 4C ). The finding is in accordance with the previous reports in which CD133 + cells have shown were exposed to 4 Gy of irradiation. Forty-eight hours after irradiation, CD133 and CD44 populations were to be more resistance to irradiation than CD133 − cells (5,49). evaluated in NANK and we found no significant increase in these two populations (for CD133 expression Production of Cytokines and Growth Factors in NANK of NANK: before = 0.1%, after = 0.095%, isotype control = 0.83%; for CD44 expression of NANK: before =
We analyzed the conditioned medium of NANK to know whether NANK produced any cytokine responsi-0.16%, after = 0.19%, isotype control = 0.22%) (Fig.  4A, B) . At least three independent experiments were ble for the tumorigenic potential. NANK secreted many cytokines involved in angiogenesis, one of the condi-performed in different passages of NANK. Next we investigated a biological difference in irradiation sensitiv-tions necessary for cancer metastasis and to sustain tumor growth, such as angiogenin, epidermal growth fac-ity between NANK and SW620, which contains high percentage of conventional CSC markers CD133 and tor (EGF), granulocyte colony-stimulation factor (GCSF), tumor necrosis factor-α (TNF-α), vascular endothelial CD44 (unpublished data), by exposing the cells to 4 Gy of irradiation. NANK was more sensitive to irradiation growth factor (VEGF), angiopoietin, and ENA-78. NANK cells also produced considerable amounts of IL-than SW620, showing a nonsignificant decrease in the 1a and IL-1b, which have also been shown to promote 1 × 10 5 were intraperitoneally transplanted in NOD/ SCID mice. When 1 × 10 4 CD133 − cells were trans-tumor invasiveness and angiogenesis (44).
planted, two out of three mice developed tumors, In Vivo Tumor-Initiating Ability of NANK whereas in mice transplanted with 5 × 10 4 and 1 × 10 5 cells, tumors were developed in all of them and in a In order to identify the presence of cancer stem cells in NANK, by means of the surface marker CD133, shorter period of time (Fig. 5B) . The animals showed peritoneal dissemination with ascities ( Fig. 5C ). Evalua-which has been demonstrated to be present in several normal and malignant stem cells of different tissues tion of the ascitic fluid revealed high levels of CEA and CA-19-9 ( Fig. 5D ). (14, 31, 34) , and have been considered to be tumor-initiating cells, NANK cells were labeled with CD133 anti-
Analysis of Tumors Developed After NANK Cells bodies and analyzed by FACS. FACS analysis revealed
Transplanted in Mice the absence of CD133 + cells in NANK (Fig. 5A) . In order to test whether this CD133 − population was capable H&E staining of tumors grown in mice after injection of CD133 − NANK revealed the formation of tumors pro-of initiating tumor formation, as was previously reported (36) , NANK cells at a density of 1 × 10 4 , 5 × 10 4 , and ducing mucin, with glandular formation, thus sharing some of the characteristics from the xenograft tumors. maintained a very similar immunohistological characterization with exception of p21, which was not analyzed These tumors were predominantly poorly differentiated adenocarcinomas. When stained for CDX-2, only focal in these tumors (Fig. 6B, C) , tumors derived from NANK showed two main immunohistological alter-expression was found in very few areas, mainly with no reactivity for this marker (Fig. 6A) . In contrast, a diffuse ations: the loss of CDX-2 and the acquisition of CK 7 (Fig. 6A) . immunoreactivity for both CK 7 and CK 20 was positively observed in NANK-initiating tumors (Fig. 6A) .
Tumors Derived From Transplanted NANK The tumors derived from NANK cell injection demon-Cells Recapitulated the Phenotype of the Primary strated a positive and diffuse immunoreactivity for p53, Colonic and Metastatic Ovarian Cancers in Terms indicating the presence of a mutated form of p53 proof CSC Markers tein, whereas p21, which is a downstream of p53, was almost absent in the tumor tissues ( Fig. 6A) . We found Next, the expression of CD133 and CD44, both of which were previously reported as consensus CSC a very clear and diffuse immunoreactivity for PCNA, a marker of cell cycle, in the tumors. NANK-derived tu-markers, was examined in the primary colon cancer, its metastatic cancer to the ovary, and tumors derived from mors were immunohistologically compared with those derived from the xenograft tissues developed after the NANK cell injection by immunohistochemistry. Both CD133 and CD44 were positive in the primary colon implantation of the primary colon and ovary metastatic tumors. While the colon and ovarian xenograft tissues tumor and ovarian metastatic tumor (Fig. 6D ). Interest- ingly, the tumor derived from NANK comprised the tion can initiate tumor development (31, 34, 38) . Although it has been recently proposed that not only mixture of CD133 − (major population) and weakly CD133 + cells (very minor population), which was simi-CD133 + cells but also CD133 − cells are endowed with tumorigenic capabilities when derived from metastatic larly observed as a mixture of CD44 − and weak CD44 + cells. These results indicated that NANK, not totally but tumors (36) . To date, there is a wide variety of markers used to partially, recapitulated the same immunophenotypes as their primary and metastatic counterparts (Fig. 6D) .
identify CSCs from other cancers: CD44 + /CD24 − for breast tumors (1), Sca-1 + /CD45 − /PECAM − /CD34 + for ade-DISCUSSION nocarcinomas (22) , and CD44 + /α2β1 + /CD133 for prostate cancers (8) , which suggests that there are not perfect In the process of tumorigenesis many factors are believed to play an important role. Among them, CSCs are markers to represent CSCs. In addition, the ability to form tumors depends not only on properties inherent to believed to have the tumor-initiating capacity in many cancers. The isolation of these cells have been possible cancer cells, but also on the host microenvironment, which plays a major role in tumor initiation and progres-in a variety of tumors (14, 31, 34, 36) through different surface markers, such as CD133 for colon and brain tu-sion (13, 29) . We here demonstrated that a cell line derived from mors where it is believed that only the CD133 + popula-colon metastasis to the ovary, NANK, lacking the sur-mas in the ovary (41, 46) . The expression of CK 20 is restricted to a limited group of adenocarcinomas. It is face marker CD133, was able to initiate tumors when transplanted intraperitoneally into NOD/SCID mice. detectable in almost all colon cancers, about half of gastric and pancreato-biliary carcinomas, and about 30% of Moreover, we also analyzed the possibility of NANK to contain a subpopulation positive for the other well-transitional cell carcinomas (6). Although several patterns have been reported (6,15), our findings are in ac-known stem cell marker CD44 and we found no expression of CD44 by RT-PCR and FACS analyses (Figs. 3 cordance with some reports where metastatic ovarian carcinomas from lower gastrointestinal tract origin are and 4). In spite of these findings, NANK cells were capable of developing aggressive peritoneal tumor dissem-CDX-2 + /CK 20 + /CK 7 − . The xenograft tissues from which NANK cells were derived preserved the same ination in the mice with ascities formation and showing high levels of tumor markers CEA and CA19-9 in the pattern of CDX-2 + /CK 20 + /CK 7 − . CDX-2 is a member of the caudal-related homeobox ascitic fluid. The tumors recapitulated the features of the parental colon and its metastatic ovarian tumors.
family and is an intestine-specific transcription factor that regulates both proliferation and differentiation in in-First, we sought to determine the origin of the metastatic ovarian tumor. Clinically, the expression of CK testinal epithelial cells. It has been shown to be expressed in a high proportion of colon carcinoma (61-20, as well as CK 7 and CDX-2, has been used to discern the primary lesions from metastatic adenocarcino-100%) (20, 41, 46) , or be downregulated in the later stages of human colon carcinogenesis, namely, high-cers (23,43), and it is believed to confer a high degree of malignancy when BMI-1 is coexpressed with other grade dysplasia and invasive carcinoma (10) . We found CDX-2 to be expressed in NANK, which might account proteins from the PcG, such as EZH2 (4). Moreover, NANK expressed p53 and APC, which are well-known for the spontaneous differentiation of the cells once they reach confluency ( Fig. 2A) . In addition, we found the markers to be mutated in several cancer cell lines. These markers in combination with the apoptosis inhibitor Bcl-expression of CK 20 and absence of CK 7 in NANK in vitro, similar to the pattern found in the primary colon xL conferred NANK cells a mechanism to survive and proliferate malignantly. and its metastatic ovarian cancers as well as in the xenograft tissues (Figs. 2 and 3) .
Angiogenesis performs a critical role in the development of cancers and influences the dissemination of can-Self-renewing activity and extensive proliferation are some of the hallmarks of stem/progenitor cells in cul-cer cells throughout the entire body, eventually leading to metastasis formation. NANK cells produced several ture, and, to some extent, these capabilities are believed to be conferred by the expression of Nanog and Oct-4 proangiogenic factors such as VEGF-D, IL-1α, and IL-1β, which are required for in vivo angiogenesis and have genes (11, 30) . NANK cells did not express these selfrenewal markers, but instead they had another mecha-been associated with the promotion of metastatic spread of tumor cells (39, 44) . VEGF expressed in tumors is nism to proliferate by expressing the polycomb group gene BMI-1, which is recognized to play an essential identified as responsible for the formation of tumor vessels that not only allow for progression of the primary role in regulating the proliferative activity of both normal and leukemia stem cells (17, 26, 32) . Overexpression tumors, but also facilitate cancer cells to access the tumor vessels (12, 44) . In accordance with these findings, of BMI-1 was in fact described in several types of can-we can speculate that the high expression of growth fac-2 is associated with progression to the more advanced stages of colorectal tumorigenesis (16, 27) . The de-tors related with angiogenesis by NANK could be one of the many factors bestowing them with a metastatic creased CDX-2 expression in NANK-derived tumors is correlated with the histological status of poorly differen-potential.
As previously mentioned, NANK cells did not ex-tiated adenocarcinomas. When CDX-2 was diffusely expressed in the tumors, they were diagnosed as moder-press CD133 or CD44, expressed in normal and cancer stem cells, nor did they express the self-renewal genes ately differentiated adenocarcinomas. The histological findings of NANK-derived tumor are in accordance with Oct4 and Nanog. However, NANK cells had the potential to initiate tumor formation when a small number of previous studies suggesting the critical role of CDX-2 in the maintenance of the intestinal phenotype (37). CDX-2 cells were intraperitoneally transplanted, in accordance with the previous reports in which transplantation of a is also suggested as a proliferation inhibitor through the upregulation of the p21 gene, considered to be a tran-CD133 − population (36) was capable of developing tumors. It is also possible that the presence of a small scriptional target of CDX-2 (2). The absence or almost no expression of CDX-2 in subset of CSC is contained in NANK. Identification of such a subset that may be responsible for its malignant NANK-derived tumors resulted in the downregulation of p21. In addition, the status of p53 was mutated in potential is now under investigation.
The property of resistance to chemotherapy and irra-NANK tumors, leading to the loss of the effect in p21. Therefore, cell cycle inhibition was not accomplished diation is the major clinical criterion to characterize "cancer stem-like cells" (19). The existence of cancer in the tumor cells, which was supported by the wide expression of PCNA ( Fig. 6A ). stem-like cells may explain why conventional anticancer therapies are able only to suppress or shrink a tumor but
In conclusion, we have shown that our newly established human colon cancer cell line NANK lacks the often cannot completely eradicate such cells, resulting in eventual recurrence of tumors (7, 19) . NANK cells in important conventional CSC markers such as CD133 and CD44, Nanog, and Oct/4, while being capable of vitro were comparably sensitive to irradiation (to slightly higher extent) when compared with SW620 that initiating tumors and developing aggressive progression with CEA and CA-19-9 synthesis and metastatic poten-possess a high percentage of CD133 + and CD44 + cells (unpublished data). The finding may indicate that tial in NOD/SCID mice. These findings may contribute to provide another novel aspect of CSC biology. NANK is not endowed with neither of the well-known CSC markers CD133 and CD44, thus leading to be irradiation sensitive in vitro. Interestingly, when NANK REFERENCES was transplanted in NOD/SCID mice, CD133-and
